We are international
Donate
TEXT SIZE   


Understanding Farydak® (panobinostat) capsules

Farydak is the first histone deacetylase (HDAC) inhibitor approved for use in treating myeloma. Farydak is an oral prescription medication taken in capsule form in combination with Velcade® (bortezomib) and dexamethasone. This booklet provides information about how Farydak works, how and when to take it, at what point in myeloma treatment it is used most effectively, its possible side effects, and how to manage those side effects.

08.25.16


click here to view PDF

Farydak is an oral medication taken in capsule form in combination with Velcade® (bortezomib) and dexamethasone. Farydak is not administered at a medical clinic or doctor’s office, so it is the patient’s responsibility to take this medication as prescribed. It is crucial that you read and understand the information in this booklet and in any other materials that your healthcare provider gives you about Farydak. If you are a patient taking Farydak, you must make sure to adhere to the prescribed dose and schedule of this oral medication, follow all safety measures, and promptly report any and all side effects to the doctors and nurses who oversee your care.


 related articles